Investor's Fiduciary Advisor Network’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$533K Buy
8,801
+253
+3% +$14.7K 0.16% 151
2025
Q4
$461K Buy
8,548
+578
+7% +$27.8K 0.1% 181
2025
Q3
$359K Buy
7,970
+4
+0.1% +$187 0.12% 173
2025
Q2
$368K Buy
+7,966
New +$391K 0.14% 159
2025
Q1
Sell
-8,200
Closed -$463K 171
2024
Q4
$463K Buy
+8,200
New +$458K 0.18% 135

Other funds holding BMY

Investor's Fiduciary Advisor Network's BMY Position: Q1 2026 in Review

Investor's Fiduciary Advisor Network increased its Bristol-Myers Squibb (BMY) stake by 3% in Q1 2026, buying an estimated $14.7K and bringing the position to 8,801 shares worth $533K. The position accounts for 0.16% of the portfolio, ranked #151.

Investor's Fiduciary Advisor Network first reported a position in BMY in Q4 2024 and has held it in 5 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Investor's Fiduciary Advisor Network held 8,801 shares of Bristol-Myers Squibb worth $533K as of Q1 2026.
  • Investor's Fiduciary Advisor Network bought 253 Bristol-Myers Squibb shares in Q1 2026, an estimated $14.7K.
  • Bristol-Myers Squibb made up 0.16% of Investor's Fiduciary Advisor Network's portfolio in Q1 2026, its #151 holding.
  • Investor's Fiduciary Advisor Network first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 5 quarters since.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Investor's Fiduciary Advisor Network's 13F filing for Q1 2026, filed 12 May 2026.